Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock, the once-high-flying Wall Street favorite, suffered not just one, but several major blows that knocked the company down to its knees.
The Canadian pharmaceutical company struggled and lost more than 87% in stock value over the past year. VRX stock went down from its highest trading price of $217.07 per share to as low as $18.55 per share over the past 52 weeks.
VRX stock closed $27.72 per share, up 3.24% on the New York Stock Exchange (NYSE) on September 23. Over the past three months, VRX stock.
Den vollständigen Artikel lesen ...
The Canadian pharmaceutical company struggled and lost more than 87% in stock value over the past year. VRX stock went down from its highest trading price of $217.07 per share to as low as $18.55 per share over the past 52 weeks.
VRX stock closed $27.72 per share, up 3.24% on the New York Stock Exchange (NYSE) on September 23. Over the past three months, VRX stock.
Den vollständigen Artikel lesen ...